Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profiling

18 Dec 2024

Abstract excerpt

BACKGROUND: Aberrant embryo implantation and suboptimal placentation can lead to (severe) complications such as preeclampsia and fetal growth restriction later in pregnancy. Current identification of high-risk pregnancies relies on a combination of risk factors, biomarkers, and ultrasound examinations, a relatively inaccurate approach. Previously, aberrant DNA methylation due to placental hypoxia has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Maternal and fetal healthcare
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39695764
DOI: 10.1186/s13148-024-01798-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profilingPMID 39695764Read ↗

DNA Methylation as a Biomarker for PreeclampsiaSemantic proximity Read ↗

Exploration of cfDNA landscape in NIPT and clinical utilities of cfDNA based gene expression inference in prenatal diagnosticsSemantic proximity Read ↗

Hypertensive disorders of pregnancy share common cfDNA methylation profilesSemantic proximity Read ↗

Preeclampsia risk prediction from prenatal cell-free DNA screeningSemantic proximity Read ↗

High-throughput methylome analysis reveals differential methylation for early and late onset preeclampsia for mothers and their childrenSemantic proximity Read ↗

Epigenetic phenotype of plasma cell-free DNA in the prediction of early-onset preeclampsia.Semantic proximity Read ↗

Cell-free DNA Methylation and Transcriptomic Signature Prediction of Pregnancies with Adverse OutcomesSemantic proximity Read ↗

Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factorsSemantic proximity Read ↗

Cell-free DNA methylome analysis for early preeclampsia predictionSemantic proximity Read ↗

Profiling (placental) DNA methylation in cell-free DNA across gestation: the Rotterdam Periconception CohortSemantic proximity Read ↗

Enrichment of methylated cell-free placental DNASemantic proximity Read ↗

eoPred: Predicting the placental phenotype of early-onset preeclampsia using DNA methylationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.